224 related articles for article (PubMed ID: 21744470)
21. Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation.
Pompili M; Pacella CM; Francica G; Angelico M; Tisone G; Craboledda P; Nicolardi E; Rapaccini GL; Gasbarrini G
Eur J Radiol; 2010 Jun; 74(3):e6-e11. PubMed ID: 19345541
[TBL] [Abstract][Full Text] [Related]
22. Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation.
Kita Y; Klintmalm G; Kobayashi S; Yanaga K
Dig Dis Sci; 2007 Dec; 52(12):3392-3. PubMed ID: 17404871
[No Abstract] [Full Text] [Related]
23. [Screening for hepatocellular carcinoma in cirrhotic patients].
Beaugrand M
Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B92-4. PubMed ID: 10891771
[No Abstract] [Full Text] [Related]
24. Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease.
Park MS; Han KH; Kim SU
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):501-11. PubMed ID: 24939348
[TBL] [Abstract][Full Text] [Related]
25. Which matters most: number of tumors, size of the largest tumor, or total tumor volume?
Germani G; Gurusamy K; Garcovich M; Toso C; Fede G; Hemming A; Suh KS; Weber A; Burroughs AK
Liver Transpl; 2011 Oct; 17 Suppl 2():S58-66. PubMed ID: 21584928
[No Abstract] [Full Text] [Related]
26. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Song ZZ
Hepatology; 2008 Jun; 47(6):2145-6; author reply 2146-7. PubMed ID: 18508292
[No Abstract] [Full Text] [Related]
27. [Preoperative evaluation and postoperative complications with prognostic impact of surgical resection for the hepatocellular carcinoma in cirrhotics].
Kang KJ
Korean J Hepatol; 2006 Dec; 12(4):479-83. PubMed ID: 17237625
[No Abstract] [Full Text] [Related]
28. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
[TBL] [Abstract][Full Text] [Related]
29. Reply: selection criteria for liver transplantation in patients with hepatocellular carcinoma: beyond tumor size and number?
Otto G
Liver Transpl; 2007 Mar; 13(3):470-1. PubMed ID: 17318868
[No Abstract] [Full Text] [Related]
30. Improving the waiting list by using 75-year-old donors for recipients with hepatocellular carcinoma.
Cascales Campos PA; Romero PR; Gonzalez R; Zambudio AR; Martinez Frutos IM; de la Peña J; Bueno FS; Robles Campos R; Miras M; Pons Miñano JA; Sanmartin Monzo A; Domingo J; Bixquert Montagud V; Parrilla Paricio P
Transplant Proc; 2010 Mar; 42(2):627-30. PubMed ID: 20304209
[TBL] [Abstract][Full Text] [Related]
31. [Variable clinical symptoms of hepatocellular carcinoma].
Struve C; Heusermann U
Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
[TBL] [Abstract][Full Text] [Related]
32. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
Silva M; Moya A; Berenguer M; Sanjuan F; López-Andujar R; Pareja E; Torres-Quevedo R; Aguilera V; Montalva E; De Juan M; Mattos A; Prieto M; Mir J
Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681
[TBL] [Abstract][Full Text] [Related]
33. Management of pre-liver transplantation patients--part 1.
Sharma P; Rakela J
Liver Transpl; 2005 Feb; 11(2):124-33. PubMed ID: 15666386
[No Abstract] [Full Text] [Related]
34. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.
Wald C; Russo MW; Heimbach JK; Hussain HK; Pomfret EA; Bruix J
Radiology; 2013 Feb; 266(2):376-82. PubMed ID: 23362092
[No Abstract] [Full Text] [Related]
35. Immunosuppression and hepatocellular carcinoma.
Schlitt HJ; Mornex F; Shaked A; Trotter JF
Liver Transpl; 2011 Oct; 17 Suppl 2():S159-61. PubMed ID: 21506251
[No Abstract] [Full Text] [Related]
36. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
Kaido T; Takada Y; Uemoto S
Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
[No Abstract] [Full Text] [Related]
37. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
38. Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations.
Pomfret EA; Lodge JP; Villamil FG; Siegler M
Liver Transpl; 2011 Oct; 17 Suppl 2():S128-32. PubMed ID: 21656657
[No Abstract] [Full Text] [Related]
39. Current controversies surrounding liver transplantation for hepatocellular carcinoma.
Silva MF; Wigg AJ
J Gastroenterol Hepatol; 2010 Jul; 25(7):1217-26. PubMed ID: 20594247
[TBL] [Abstract][Full Text] [Related]
40. [Surgical treatment for small hepatocellular carcinoma].
Eguchi S; Furui J; Yanaga K; Kanematsu T
Nihon Rinsho; 2001 Oct; 59 Suppl 6():511-5. PubMed ID: 11762003
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
